Clinical Trial Update: The KHENERGY Study [Phase 2]

View source ↗

Summary

Phase 2 trial update for the KHENERGY study in mitochondrial diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melas
• Midd
• Mitochondrial Diseases
• Mitochondrial Encephalomyopathies
• Mitochondrial Myopathies

Drugs mentioned

• KHENERGY

Snippet

Sponsor: Khondrion BV | Conditions: Mitochondrial Diseases, Mitochondrial Myopathies | Phase 2 | Status: COMPLETED